Corbus Pharmaceuticals (CRBP) stock drops 12% after mixed Phase 1 trial results for its lead cancer candidate. Read more here.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) announced that data from its US and UK first-in-human dose escalation ...

Valentine’s Day celebrates love, but true care includes protecting loved ones from preventable diseases. The HPV vaccine is ...

23. Dahiya D, Mackin C, Nigam PS. Studies on bioactivities of Manuka and regional varieties of honey for their potential use ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Experts say a healthy vaginal microbiome may cut down one's risk of infections like HPV in check. Probiotics can balance pH, ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.